drugset / Trial / NCT01510899
A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838
Non-randomizedParallel-groupOpen-label
Summary
This open-label, single-dose, parallel-group study will investigate the pharmacokinetics and safety of RO4917838 in healthy and renal impaired subjects. Subjects will receive a single dose of RO4917838.
Timeline
- Start
- 2011-10
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bitopertin | Small molecule | — | — |
Indications
No indication recorded.